U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 24-30, 2019
  1. FDA Meetings, Conferences and Workshops

Public Calendar: March 24-30, 2019

Public Calendar: March 24-30, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 03/25/2019
Location: Silver Spring, MD
Subject: Youth Tobacco Prevention
FDA Participant/Group: LAUREN ROTH; ANN SIMONEAU; CARLYLE MCWILLIAMS; JOSEPHINE TROPEA; MICHELE MITAL; LAUREN SILVIS; MITCHELL ZELLER; AMY ABERNETHY; DAVID MEDNICK; ANNA ABRAM;
Non FDA Participant/Group: David Graham, Jeff Weiss, Ryan Nivakoff (NJOY);

Event Date: 03/27/2019
Location: Washington, DC
Subject: National Coalition for Cancer Survivorship: Cancer Policy Roundtable
FDA Participant/Group: KATHLEEN QUINN;
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Event Date: 03/29/2019
Location: Washington, DC
Subject: Alliance for a Stronger FDA
FDA Participant/Group: LAUREN SILVIS; KATHLEEN QUINN;
Non FDA Participant/Group: Government, media, industry, and other invited guests

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 03/25/2019
Location: Silver Spring, MD
Subject: Global Teen Challenge: Building a Wide-Scale Addiction Recovery Dataset to Help Address the Opioid Epidemic
FDA Participant/Group: KRISTINE MORAN; LAUREN ROTH; DAYLE CRISTINZIO; EMILY HELMS WILLIAMS; JAMES FLAHIVE;
Non FDA Participant/Group: Gary Blackard, Tim Kincaid (Global Teen Challenge); Bill Dudley (Dudley Strategies);

Event Date: 03/27/2019
Location: Washington, DC
Subject: 2019 Health Datapalooza: Accomplishments of FDA's Digital Health Innovation Plan
FDA Participant/Group: SEAN KHOZIN; PAUL HOWARD; LONNIE SMITH;
Non FDA Participant/Group: Simmi Singh (Egon Zehnder International Ltd.), several members from AcademyHealth, the National Institutes of Health, and the Centers for Disease Control and Prevention

Event Date: 03/28/2019
Location: Washington, DC
Subject: Deloitte Women in Leadership Series
FDA Participant/Group: ANGELIQUE HEBERT;
Non FDA Participant/Group: N/A

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

Event Date: 03/29/2019
Location: Silver Spring, MD
Subject: FDA Drug Shortages Task Force Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Diane Hustead, Frank Reale, Kimberly Duffy (Merck Sharp & Dohme Corp.); Meredyth Andrus (Federal Trade Commission);

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/27/2019
Location: Boston, MA
Subject: 3rd Annual Gene Therapy for Rare Disorders Conference: Defining a Harmonized, Globally-Applicable Regulatory Framework for Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 03/28/2019
Location: Silver Spring, MD
Subject: Alliance for Regenerative Medicine/FDA Liaison Meeting
FDA Participant/Group: Several CBER officials and staff members
Non FDA Participant/Group: Several representatives from the Alliance for Regenerative Medicine

Event Date: 03/28/2019
Location: Boston, MA
Subject: 3rd Annual Gene Therapy for Rare Disorders Conference: FDA’s Efforts to Facilitate the Development and Availability of Gene Therapy Products
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/26/2019
Location: Washington, DC
Subject: EXCITE International Health Technology Global Summit: Changing U.S. Regulatory Landscape
FDA Participant/Group: MURRAY SHELDON;
Non FDA Participant/Group: N/A

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event